Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months. [electronic resource]
Producer: 20180319Description: e177-e184 p. digitalISSN:- 1969-6213
- Absorbable Implants
- Aged
- Aspirin -- administration & dosage
- Cardiovascular Agents -- administration & dosage
- Clopidogrel
- Coated Materials, Biocompatible
- Coronary Thrombosis -- diagnosis
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Humans
- Incidence
- Male
- Middle Aged
- Netherlands -- epidemiology
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Prosthesis Design
- Registries
- Retrospective Studies
- Risk Factors
- Ticlopidine -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.